Production (Stage)
GRI Bio, Inc.
GRI
$1.30
-$0.08-5.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.41M | 1.13M | 1.00M | 1.38M | 962.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.05M | 1.95M | 2.13M | 2.26M | 1.90M |
| Operating Income | -3.05M | -1.95M | -2.13M | -2.26M | -1.90M |
| Income Before Tax | -3.05M | -5.81M | -2.12M | -2.25M | -1.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.05M | -5.81M | -2.12M | -2.25M | -1.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.05M | -5.81M | -2.12M | -2.25M | -1.89M |
| EBIT | -3.05M | -1.95M | -2.13M | -2.26M | -1.90M |
| EBITDA | -3.05M | -1.95M | -2.13M | -2.26M | -1.89M |
| EPS Basic | -5.80 | -7.86 | -11.42 | -83.56 | -101.10 |
| Normalized Basic EPS | -3.62 | -2.48 | -7.14 | -52.23 | -63.19 |
| EPS Diluted | -5.80 | -15.72 | -11.42 | -83.56 | -101.10 |
| Normalized Diluted EPS | -3.62 | -2.48 | -7.14 | -52.23 | -63.19 |
| Average Basic Shares Outstanding | 525.40K | 491.00K | 185.90K | 26.90K | 18.70K |
| Average Diluted Shares Outstanding | 525.40K | 491.00K | 185.90K | 26.90K | 18.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |